Literature DB >> 31449686

The Clinical Course after Long-Term Acute Care Hospital Admission among Older Medicare Beneficiaries.

Anil N Makam1,2,3, Thu Tran4, Michael E Miller2, Lei Xuan2, Oanh Kieu Nguyen1,2,3, Ethan A Halm1,2.   

Abstract

OBJECTIVES: Long-term acute care (LTAC) hospitals provide extended complex post-acute care to more than 120 000 Medicare beneficiaries annually, with the goal of helping patients to regain independence and recover. Because little is known about patients' long-term outcomes, we sought to examine the clinical course after LTAC admission.
DESIGN: Nationally representative 5-year cohort study using 5% Medicare data from 2009 to 2013.
SETTING: LTAC hospitals. PARTICIPANTS: Hospitalized Medicare fee-for-service beneficiaries 65 years of age or older who were transferred to an LTAC hospital. MEASUREMENTS: Mortality, recovery (defined as achieving 60 consecutive days alive without inpatient care), time spent in an inpatient facility following LTAC hospital admission, receipt of an artificial life-prolonging procedure (feeding tube, tracheostomy, hemodialysis), and palliative care physician consultation.
RESULTS: Of 14 072 hospitalized older adults transferred to an LTAC hospital, median survival was 8.3 months, and 1- and 5-year survival rates were 45% and 18%, respectively. Following LTAC admission, 53% never achieved a 60-day recovery. The median time of their remaining life a patient spent as an inpatient after LTAC admission was 65.6% (interquartile range = 21.4%-100%). More than one-third (36.9%) died in an inpatient setting, never returning home after the LTAC admission. During the preceding hospitalization and index LTAC admission, 30.9% received an artificial life-prolonging procedure, and 1% had a palliative care physician consultation.
CONCLUSION: Hospitalized older adults transferred to LTAC hospitals have poor survival, spend most of their remaining life as an inpatient, and frequently undergo life-prolonging procedures. This prognostic understanding is essential to inform goals of care discussions and prioritize healthcare needs for hospitalized older adults admitted to LTAC hospitals. Given the exceedingly low rates of palliative care consultations, future research is needed to examine unmet palliative care needs in this population. J Am Geriatr Soc 67:2282-2288, 2019.
© 2019 The American Geriatrics Society.

Entities:  

Keywords:  Medicare; older adults; palliative care; post-acute care; prognosis

Mesh:

Year:  2019        PMID: 31449686     DOI: 10.1111/jgs.16106

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

1.  National Trends in Potentially Preventable Hospitalizations of Older Adults with Dementia.

Authors:  Timothy S Anderson; Edward R Marcantonio; Ellen P McCarthy; Shoshana J Herzig
Journal:  J Am Geriatr Soc       Date:  2020-07-23       Impact factor: 7.538

2.  The Role of the Long-Term Acute Care Hospital Following Critical Illness-Has the Coronavirus Disease 2019 Pandemic Demonstrated Their Usefulness or Emphasized Their Downside?

Authors:  Paul Morgan
Journal:  Crit Care Med       Date:  2022-02-01       Impact factor: 9.296

3.  Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients.

Authors:  Catherine L Auriemma; Stephanie P Taylor; Michael O Harhay; Katherine R Courtright; Scott D Halpern
Journal:  Am J Respir Crit Care Med       Date:  2021-10-15       Impact factor: 30.528

4.  Time-Critical Goals of Care in the Emergency Department During COVID-19: A Three-Stage Protocol.

Authors:  Shunichi Nakagawa; Liliya Abrukin; Craig D Blinderman
Journal:  J Am Geriatr Soc       Date:  2020-07-06       Impact factor: 7.538

5.  Comparative effectiveness of long-term acute care hospital versus skilled nursing facility transfer.

Authors:  Anil N Makam; Oanh Kieu Nguyen; Michael E Miller; Sachin J Shah; Kandice A Kapinos; Ethan A Halm
Journal:  BMC Health Serv Res       Date:  2020-11-11       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.